Variability of retinopathy consequent upon novel mutations in LAMA1

References

• Poretti A, Häusler M, Von Moers A, Baumgartner B, Zerres K, Klein A, Aiello C, Moro F, Zanni G, Santorelli FM, et al. Ataxia, intellectual disability, and ocular apraxia with cerebellar cysts: a new disease? Cerebellum. 2014;13(1):79–88. doi:10.1007/s12311-013-0521-8.
   PubMedGoogle Scholar
• Aldinger KA, Mosca SJ, Tétreault M, Dempsey JC, Ishak GE, Hartley T, Phelps IG, Lamont RE, O’-Day DR, Basel D, et al. Mutations in LAMA1 cause cerebellar dysplasia and cysts with and without retinal dystrophy. Am J Hum Genet. 2014;95(4):472. doi:10.1016/j.ajhg.2014.07.007.
   Google Scholar
• Yao Y. Laminin: loss-of-function studies. Cell Mol Life Sci. 2017;74(6):1095–115. doi:10.1007/s00018-016-2381-0.
   PubMedGoogle Scholar
• Vilboux T, Malicdan MCV, Chang YM, Guo J, Zerfas PM, Stephen J, Cullinane AR, Bryant J, Fischer R, Brooks BP, et al. Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defects. J Med Genet. 2016;53(5):318–29. doi:10.1136/jmedgenet-2015-103416.
   PubMedGoogle Scholar
• Edwards MM, Mammadova-Bach E, Alpy F, Klein A, Hicks WL, Roux M, Simon-Assmann P, Smith RS, Orend G, Wu J, et al. Mutations in LAMA1 disrupt retinal vascular development and inner limiting membrane formation. J Biol Chem. 2010;285(10):7697–711. doi:10.1074/jbc.M109.069575.
   PubMedGoogle Scholar
• Ichikawa-Tomikawa N, Ogawa J, Douet V, Xu Z, Kamikubo Y, Sakurai T, Kohsaka S, Chiba H, Hattori N, Yamada Y, et al. Laminin Α1 is essential for mouse cerebellar development. Matrix Biol. 2012;31(1):17–28. doi:10.1016/j.matbio.2011.09.002.
   PubMedGoogle Scholar
• Biehlmaier O, Makhankov Y, Neuhauss SCF. Impaired retinal differentiation and maintenance in Zebrafish laminin mutants. Investig Ophthalmol Vis Sci. 2007;48(6). doi:10.1167/iovs.06-1212.
   PubMedGoogle Scholar
• Turnbull C, Scott RH, Thomas E, Jones L, Murugaesu N, Pretty FB, Halai D, Baple E, Craig C, Hamblin A, et al. The 100 000 genomes project: bringing whole genome sequencing to the NHS. Bmj. 2018;361:361. doi:10.1136/bmj.k1687.
   Google Scholar
• 100,000 genomes pilot on rare-disease diagnosis in health care — preliminary report. N Engl J Med. 2021;385(20):1868–80. doi:10.1056/NEJMoa2035790.
   PubMedGoogle Scholar
• Carss KJ, Arno G, Erwood M, Stephens J, Sanchis-Juan A, Hull S, Megy K, Grozeva D, Dewhurst E, Malka S, et al. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am J Hum Genet. 2017;100(1):75–90. doi:10.1016/j.ajhg.2016.12.003.
   PubMed Web of Science ®Google Scholar
• Bach M, Brigell MG, Hawlina M, Holder GE, Johnson MA, McCulloch DL, Meigen T, Viswanathan S. ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol. 2013;126(1):1–7. doi:10.1007/s10633-012-9353-y.
   PubMed Web of Science ®Google Scholar
• Audo I, Michaelides M, Robson AG, Hawlina M, Vaclavik V, Sandbach JM, Neveu MM, Hogg CR, Hunt DM, Moore AT, et al. Phenotypic variation in enhanced S-cone syndrome. Investig Ophthalmol Vis Sci. 2008;49(5):2082–93. doi:10.1167/iovs.05-1629.
   PubMedGoogle Scholar
• Sustar M, Holder GE, Kremers J, Barnes CS, Lei B, Khan NW, Robson AG. ISCEV extended protocol for the photopic on–off ERG. Doc Ophthalmol. 2018;136(3):199–206. doi:10.1007/s10633-018-9645-y.
   PubMedGoogle Scholar
• Perlman I, Rappaport B, Kondo M, Chelva E, Robson AG, Holder GE. ISCEV extended protocol for the S-cone ERG. Doc Ophthalmol. 2020;140(2):95–101. doi:10.1007/s10633-019-09730-6.
   PubMedGoogle Scholar
• Holder GE, Robson AG. Paediatric electrophysiology: a practical approach. In: Pediatric ophthalmology, neuro-ophthalmology, genetics. Berlin (Heidelberg): Springer-Verlag; 2006. p. 133–55. doi:10.1007/3-540-31220-x_9.
   Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. doi:10.1038/gim.2015.30.
   PubMed Web of Science ®Google Scholar
• Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. Integrative genomics viewer. doi:10.1038/nbt.1754.
   Google Scholar
• Micalizzi A, Poretti A, Romani M, Ginevrino M, Mazza T, Aiello C, Zanni G, Baumgartner B, Borgatti R, Brockmann K, et al. Clinical, neuroradiological and molecular characterization of cerebellar dysplasia with cysts (Poretti–boltshauser syndrome). Eur J Hum Genet. 2016;24(9):1262–67. doi:10.1038/ejhg.2016.19.
   PubMedGoogle Scholar
• Calì T, Lopreiato R, Shimony J, Vineyard M, Frizzarin M, Zanni G, Zanotti G, Brini M, Shinawi M, Carafoli E. A novel mutation in isoform 3 of the plasma membrane Ca2+ pump impairs cellular Ca2+ homeostasis in a patient with cerebellar ataxia and laminin subunit 1α mutations. J Biol Chem. 2015;290(26):16132–41. doi:10.1074/jbc.M115.656496.
   PubMedGoogle Scholar
• Masson R, Piretti E, Pellegrin S, Gusson E, Poretti A, Valente EM, Antalupo G. Early-onset head titubation in a child with poretti-boltshauser syndrome. Neurology. 2017;88(15):1478–79. doi:10.1212/WNL.0000000000003823.
   PubMedGoogle Scholar
• Marlow E, Chan RVP, Oltra E, Rusu I, Gupta MP. Retinal avascularity and neovascularization associated with LAMA1 (laminin 1) mutation in poretti-boltshauser syndrome. JAMA Ophthalmol. 2018;136(1):96. doi:https://doi.org/10.1001/jamaophthalmol.2017.5060.
   PubMedGoogle Scholar
• Banerjee A, Vyas S, Sankhyan N. Cerebellar cysts and dysplasias: more diagnoses to consider. Pediatr Neurol. 2019;98. doi:10.1016/j.pediatrneurol.2019.02.021.
   Google Scholar
• Chen M, Zhang M, Qian Y, Yang Y, Sun Y, Liu B, Wang L, Dong M. Identification of a likely pathogenic structural variation in the LAMA1 gene by bionano optical mapping. Npj Genomic Med. 2020;5(1):1–6. doi:10.1038/s41525-020-0138-z.
   PubMedGoogle Scholar
• Kirk EP, Barlow-Stewart K, Selvanathan A, Josephi-Taylor S, Worgan L, Rajagopalan S, Cowley MJ, Gayevskiy V, Bittles A, Burnett L, et al. Beyond the panel: preconception screening in consanguineous couples using the TruSight One “clinical exome”. Genet Med. 2019;21(3):608–12. doi:10.1038/s41436-018-0082-9.
   PubMedGoogle Scholar
• Elmas M, Gogus B, Solak M. Understanding what you have found: a family with a mutation in the LAMA1 gene with literature review. Clin Med Insights Case Reports. 2020;13. doi:10.1177/1179547620948666.
   Google Scholar
• Cai CX, Go M, Kelly MP, Holgado S, Toth CA. Ocular manifestations of poretti-boltshauser syndrome. Retin Cases Brief Rep. 2020. doi:10.1097/ICB.0000000000000991.
   Google Scholar
• Salmivirta K, Sorokin LM, Ekblom P. Differential expression of laminin chains during murine tooth development. Vol. 210. Wiley-Liss, Inc; 1997. doi:10.1002/(SICI)1097-0177(199711)210:3<206::AID-AJA2>3.0.CO;2-K.
   Google Scholar